Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers. - Wikidata - awgldk - TriplyDB

Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.

Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.

http://www.wikidata.org/entity/Q38121846

about

Galectin-Binding O-Glycosylations as Regulators of Malignancy A new method for detection of tumor driver-dependent changes of protein sialylation in a colon cancer cell line reveals nectin-3 as TGFBR2 target Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity.Immature truncated O-glycophenotype of cancer directly induces oncogenic features Protein glycosylation in cancer.Cellular O-Glycome Reporter/Amplification to explore O-glycans of living cells Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancer Aberrant glycosylation as biomarker for cancer: focus on CD43.The challenge and promise of glycomics.The cytokine-cosmc signaling axis upregulates the tumor-associated carbohydrate antigen Tn.Identification of a novel protein binding motif within the T-synthase for the molecular chaperone Cosmc.Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition.Simple sugars to complex disease--mucin-type O-glycans in cancer.Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.Upregulation of glycans containing 3' fucose in a subset of pancreatic cancers uncovered using fusion-tagged lectins.Genomic alterations in mucins across cancers Isotopic Labeling with Cellular O-glycome Reporter/Amplification (ICORA) for Comparative O-glycomics of Cultured Cells.Genetically Encoded Toolbox for Glycocalyx Engineering: Tunable Control of Cell Adhesion, Survival, and Cancer Cell Behaviors.Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau.GalNAc-T15 in gastric adenocarcinoma: Characterization according to tissue architecture and cellular location.O-linked mucin-type glycosylation in breast cancer A combined computational-experimental approach to define the structural origin of antibody recognition of sialyl-Tn, a tumor-associated carbohydrate antigen Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers

P2860

Q26801724-5C1CEB20-C618-4005-8982-F74A9CE8C41B Q33361138-75DDA5D5-CD3C-4F21-9C9E-FBD14B48498C Q33641923-8E3E4883-35AC-49A6-A132-A8BB41750B2E Q34314283-15691D51-AF11-43A1-810B-0FE3A06337FA Q35413473-0B5673CF-3572-4EE2-AD22-A4310BBA70E2 Q36420667-C1726482-3085-4A2A-B59E-99921E7F86CF Q36539502-C6A0D448-A35C-4F64-8954-21E24F54EE0E Q37565619-8BDE2440-3BC7-4A09-97AB-098ECD90A066 Q37618865-D33E4F51-0B6E-4101-9B28-AFFEF3B53976 Q37638949-57EA119B-0506-4A4A-B60E-F2E7A41DF973 Q37641712-1A5F560A-78C8-4CD6-A37F-E085C56ED3C5 Q37727574-881F6CC5-F401-4EF4-9BF0-EB59B7E0A673 Q37738102-FCE44520-B7EA-46E2-8E60-24CE3B0A2C23 Q38203883-95E3467D-291C-4A3C-B85A-515D752715B1 Q38366325-7F5493D3-596F-4A3D-808E-0C476DB8B385 Q38799856-83651B44-8D10-40A9-98AE-3D76055957F9 Q40980684-17A3363D-470C-45F8-850C-C19688054A5C Q42366534-1024AF20-7ABF-4808-B69F-F2ACA71C7729 Q49489614-855D922F-4B70-4F25-8EC4-1B52EC2FB389 Q54977954-7E75676C-C99F-4221-995E-55D0895CBCF0 Q55167285-5DC7935F-1C82-48D1-AA1C-0B2AEBCBF4E2 Q55517393-AF990351-E479-43A8-8FD7-0BA3A42755D4 Q57107715-78BDD942-D3FB-47D0-989A-7E6B1650D4D7 Q58061110-8D84924E-0168-4023-8E34-7BCDB5095784 Q58774191-7BEA6646-E316-4610-B9DF-983EAE584C00

P2860

Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.

http://www.wikidata.org/entity/Q38121846

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.

@en

type

label

Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.

@en

prefLabel

Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.

@en

P1433

Q38121846-DFA46FC9-8E68-4476-9DA3-59A645E889BC

P1476

Q38121846-059D9C77-827B-4FF9-AC22-EEB3F6238EFC

P2093

Q38121846-065ECD8A-7385-4129-B0B8-E4B7FA258103

Q38121846-157D5681-DB68-4708-B1C2-99A2DF75DBD2

Q38121846-1968C271-702F-4A83-9451-F95DB017CEC1

Q38121846-1E845213-2EED-47D8-8C9E-C957607BB0AD

Q38121846-268EF3F7-DD5E-462E-8EA7-1140523DBCAB

Q38121846-26AF5F15-C958-4BEA-8149-AECDA7DB0362

Q38121846-28C59BB1-6602-4E67-90DE-5B1E21EA3C11

Q38121846-38DB9F99-922B-4052-BDB3-3CB7F818F2C1

Q38121846-510FC1DB-013B-4868-B9F3-F2B15984EC28

Q38121846-62E4EFBC-56F1-4235-A2C1-945DA38D2D5E

P2860

Q38121846-036FAEA6-6F0B-449E-B7EE-2AF87320A513

Q38121846-039CC7F1-761D-4A9E-B435-5B42F953F4CA

Q38121846-048E96D4-D485-43E6-A8A1-1EC30EE90459

Q38121846-04D968D8-226D-40B2-9014-A05385BB9152

Q38121846-06EDFB0E-5ABF-4DE0-9843-4D2AC27B4355

Q38121846-09FC39B3-1CF3-45BD-B284-ED22938EE3D8

Q38121846-0A156F34-AA2D-4CAE-A03A-4D8B1D3A4AE0

Q38121846-0A345D61-3626-4C1F-B752-3164241C7172

Q38121846-0AB367F0-45EA-4C70-9531-23DBE0CDC8F2

Q38121846-0D9EFF09-596C-4B4C-93FD-75B930FC714B

P304

Q38121846-A0C22A0E-61CE-4D48-AC1C-D433A71F24F8

P31

Q38121846-D831FC25-54C3-40FB-888C-5D50B85995A2

P356

Q38121846-526F2A0C-34C1-44C1-8BD9-6845B8002929

P433

Q38121846-E45F5A05-D15B-4964-ADD6-B2981C46185D

P478

Q38121846-8B76D7B4-7E7D-43F1-8768-3E41CEE9DA52

P577

Q38121846-508EC2DD-EF25-43D7-BD58-95C9DC56BE60

P698

Q38121846-176079FD-18C8-4BC2-B443-DAA3BCC482AC

P932

Q38121846-A89BD50D-E232-4C0D-BF31-11929BF021B0

P356

P1433

Proteomics - Clinical Applications

P1476

Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.

@en

P2093

Christopher Cutler

http://www.w3.org/2001/XMLSchema#string

David F Smith

http://www.w3.org/2001/XMLSchema#string

Jamie Heimburg-Molinaro

http://www.w3.org/2001/XMLSchema#string

Jianmei Wang

http://www.w3.org/2001/XMLSchema#string

Junwei Zeng

http://www.w3.org/2001/XMLSchema#string

Matthew R Kudelka

http://www.w3.org/2001/XMLSchema#string

Rajindra P Aryal

http://www.w3.org/2001/XMLSchema#string

Richard D Cummings

http://www.w3.org/2001/XMLSchema#string

Sylvain D Lehoux

http://www.w3.org/2001/XMLSchema#string

Tongzhong Ju

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens

Cloning and expression of human core 1 beta1,3-galactosyltransferase

Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans

Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy

Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice

A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase

Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice

Roles of the gel-forming MUC2 mucin and its O-glycosylation in the protection against colitis and colorectal cancer

Retrotranslocation of a misfolded luminal ER protein by the ubiquitin-ligase Hrd1p.

Cosmc is an essential chaperone for correct protein O-glycosylation

P304

618-631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRCA.201300024

http://www.w3.org/2001/XMLSchema#string

P433

9-10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23857728

http://www.w3.org/2001/XMLSchema#string

P932

5808880

http://www.w3.org/2001/XMLSchema#string